Skip to main content
MDA · Thai FDA · Reliance programme, permanent from 1 May 2026

Malaysia–Thailand medical device reliance, both directions.

Since 1 May 2026 MDA and Thai FDA rely on each other’s approvals for Class B, C and D devices. A Thai-approved device takes MDA’s verification route; an MDA-registered device skips Thailand’s external expert evaluation. Here are the conditions, documents and steps each regulator published.

01 MDA Registration02 GDPMD + Licensing03 ISO 13485 QMS04 MDSAP05 CE / FDA Export
Short answer

Where things stand on 15 October 2026.

The MDA – Thai FDA Medical Device Regulatory Reliance Programme has been in full implementation since 1 May 2026 for Class B, C and D devices. It works in both directions:

  • Thai approval into Malaysia: the device uses MDA’s verification route (MDA/GD/0070) instead of full conformity assessment. A registered conformity assessment body verifies the Thai approval, and MDA reviews the application.
  • MDA registration into Thailand: the device skips Thai FDA’s external expert evaluation. The applicant still files a full CSDT, identical to the Malaysian one, with proof of MDA registration.

The Malaysian direction is not new law. Thai FDA approvals were already on MDA’s list of recognised approvals from Circular Letter No. 2 of 2025 and the Second Edition of MDA/GD/0070 (2025). What the programme added in 2026 is the Thai direction, which gives Malaysian-registered devices a shorter path into Thailand.

How the programme developed

DateWhat happened
30 September 2025MDA Circular Letter No. 2 of 2025 and MDA/GD/0070 (2nd Ed.) list Thai FDA approvals for MDA’s verification route
4 December 2025MDA and Thai FDA sign a Confidentiality Agreement at the 29th GHWP Annual Meeting in Bangkok and launch a three-month pilot
1 February – 30 April 2026Pilot phase for Class B, C and D devices
8 April 2026MDA reports pilot results in Bangkok: 15 devices registered in Malaysia, 6 under evaluation; 4 applications in Thai FDA’s assessment pipeline
1 May 2026Joint announcement: full implementation, effective immediately
15 October 2026No change announced since; MDA announcements checked to no. 1861

Thai-approved devices into Malaysia

The joint announcement points Thai-approved devices to MDA/GD/0070, MDA’s guide to registration through conformity assessment by way of verification. Annex 1 of GD/0070 sets out which Thai approvals count:

Thai classApproval MDA acceptsWith the application
Class 2–3Certificate of Notified Medical DeviceEnglish translation; manufacturer’s declaration of conformity
Class 4Certificate of Licensed Medical DeviceEnglish translation; manufacturer’s declaration of conformity

The ordinary verification conditions in GD/0070 Table 1 still apply. The device must have the same design and intended purpose as the Thai-approved device, no deaths or serious deterioration reported globally in the past year, no open field safety corrective action at submission, and no rejection or withdrawal by a recognised regulator. Approvals issued under Thailand’s section 27 exemptions for non-commercial manufacture or import do not count (GD/0070 Table 2).

  1. Classify the device under Malaysian rules. MDA sets Thai Class 2–4 beside Malaysian Classes B–D, but the Malaysian class comes from the First Schedule rules. See our classification guide.
  2. Appoint a Malaysian authorised representative with an MDA establishment licence, unless you are a Malaysian manufacturer. See our authorised representative service.
  3. A registered CAB verifies the Thai approval under MDA/GD/0068, checking the quality management system, post-market surveillance, technical documentation and Declaration of Conformity. GD/0068 estimates about 1.5 months for the CAB.
  4. Apply in MeDC@St with the CAB certificate, the Thai certificate and its translation, and the CSDT. MDA/GD/0070 gives MDA 30 working days for a Class B, C or D application once documents are complete and payment is made.

MDA-registered devices into Thailand

This is the half that is new in 2026. The joint announcement says an MDA-approved device “can bypass the external expert evaluation with full CSDT submission”. Thai FDA’s Medical Device Control Division sets the conditions:

ConditionWhat Thai FDA requires
Risk classClass B to D devices registered by MDA
ExcludedDevices covered by specific Thai notifications, and devices exempted from the quality, performance and safety evaluation, such as Class A or products under an MDA exempted product approval
SamenessTrade name, model, product code, intended purpose, indications, label, instructions and packaging identical to what MDA approved
DossierFull CSDT, the same documents used for the MDA registration
EvidenceProof of registration in Malaysia
EnquiriesInternational Cooperation Group, Medical Device Control Division, Thai FDA

Thai FDA’s application steps in its E-submission system:

  1. Prepare the application in full CSDT format.
  2. On the registration application page, select that the application is under a reliance programme, then choose “Malaysia MDA – Thai FDA Pilot Project”. A declaration appears.
  3. Read the declaration and select “I have read and fully understood this declaration”, then complete the rest of the application.
  4. Attach the full CSDT, with the evidence of Malaysian registration in the executive summary section.

E-submission is used by Thai-registered manufacturers and importers, so a Malaysian manufacturer files through its Thai importer. The joint announcement also cites a draft Thai FDA notification listing the reference agencies Thai FDA recognises. We have not seen it in final form, so check its status with Thai FDA before relying on it.

The routes compared

RouteWhich devicesWhat is shortenedStatus (Oct 2026)
Thai FDA approval → MDA verificationClass B–D with a Thai Class 2–3 notified or Class 4 licensed certificateCAB verifies the Thai approval instead of a full assessmentOpen
MDA registration → Thai FDA relianceClass B–D registered by MDA, not exempted productsNo external expert evaluation; full CSDT still filedOpen
Singapore HSA relianceClass B–D on the Singapore Medical Device RegisterCAB review 30 working days vs 60 for full assessmentPermanent since 1 March 2026
Malaysia–China pilotsChinese IVDs (2025); new devices in joint evaluation (2026)Pilot-specificBoth phases closed

Published review times for every route are on our registration timeline page.

Our reading

  • For Malaysian manufacturers, Thailand is now the easiest next market. An MDA registration is the evidence Thai FDA relies on, so a clean Malaysian CSDT pays off twice.
  • Keep the two files identical. Thai FDA wants the same CSDT, labels and packaging that MDA approved. If you change the device in Malaysia, file the change notification before you copy the new version into the Thai dossier, or the two will no longer match.
  • Class A gets no benefit. Class A devices are excluded on the Thai side and do not need the verification route in Malaysia; see our Class A guide.
  • Licences are not part of the reliance. Malaysia still requires an establishment licence and GDPMD for the AR, importer and distributors. Thailand still requires its own establishment licensing for the importer.
Jawapan ringkas · Bahasa Malaysia

Apakah program kebergantungan regulatori MDA – Thai FDA?

Sejak 1 Mei 2026, MDA dan Thai FDA melaksanakan sepenuhnya program kebergantungan regulatori untuk peranti perubatan Kelas B, C dan D. Peranti yang diluluskan Thai FDA boleh didaftarkan di Malaysia melalui laluan verifikasi (MDA/GD/0070). Peranti yang berdaftar dengan MDA boleh didaftarkan di Thailand tanpa penilaian pakar luar, tetapi masih perlu menghantar dokumen CSDT penuh yang sama seperti di Malaysia beserta bukti pendaftaran MDA. Pengilang asing tetap memerlukan wakil sah tempatan yang memegang lesen establismen MDA. WhatsApp 010-206 2070.

FAQ

Frequently asked questions

What is the MDA – Thai FDA reliance programme?
It is a two-way arrangement between Malaysia’s Medical Device Authority and the Thai Food and Drug Administration for registering Class B, C and D medical devices. The two regulators signed a Confidentiality Agreement and launched a three-month pilot at the 29th GHWP Annual Meeting in Bangkok on 4 December 2025. The pilot ran from 1 February to 30 April 2026, and a joint announcement dated 1 May 2026 moved it to full implementation.
Is the Malaysia–Thailand reliance route still a pilot?
No. The joint announcement of 1 May 2026 says the programme moves from pilot status to full implementation “effective immediately”. Thai FDA’s own pages still use the pilot name, “Malaysia MDA – Thai FDA Pilot Project”, and applicants select that option in Thai FDA’s E-submission system.
We have Thai FDA approval. How do we register in Malaysia?
Through MDA’s verification route under MDA/GD/0070. Annex 1 of GD/0070 accepts a Thai Certificate of Notified Medical Device for Thai Class 2–3 and a Certificate of Licensed Medical Device for Class 4, with an English translation and the manufacturer’s declaration of conformity. A Malaysian conformity assessment body verifies the approval, and a licensed Malaysian authorised representative or manufacturer applies in MeDC@St. MDA/GD/0070 gives MDA 30 working days for a Class B, C or D application once documents are complete.
We are registered with MDA. What does Thailand waive?
The external expert evaluation. The joint announcement says an MDA-approved device “can bypass the external expert evaluation with full CSDT submission”. The dossier is not shortened: Thai FDA asks for registration documents in full CSDT format, identical to those used for the MDA registration, plus evidence of the Malaysian registration.
Which devices cannot use the Thai side of the programme?
Thai FDA lists Class B to D devices approved by MDA, excluding devices covered by specific Thai notifications and devices exempted from the quality, performance and safety evaluation, such as Class A devices or products under an MDA exempted product approval. The trade name, model, product code, intended purpose, indications, label, instructions and packaging must be identical to what MDA approved.
How much faster is the Thai route for an MDA-registered device?
Neither regulator has published a timeline for it. The joint announcement says the route reduces duplication and speeds market access, and Thai FDA’s page describes it as fewer steps, less time and lower cost, but no number of days is given. We do not quote one.
How many devices have used the programme?
MDA reported on 8 April 2026, during the pilot, that 15 devices had been registered in Malaysia through it and 6 more were under evaluation, while Thai FDA had 4 applications in assessment. No figures have been published since full implementation.
Do we still need a Malaysian authorised representative?
Yes. Reliance changes how the device is assessed, not who may hold the registration. A foreign manufacturer still needs a Malaysian authorised representative holding an MDA establishment licence, and the importer and distributors still need their own licences and GDPMD.

Using the Malaysia–Thailand reliance route?

Send us the Thai certificate or your MDA registration, the device list and the CSDT. We will confirm whether the device qualifies, act as your licensed Malaysian authorised representative, and keep the Malaysian dossier in the form Thai FDA expects.

WhatsApp